US Broker Ratings

Candel Therapeutics, Inc. (CADL) Stock Analysis: 305% Potential Upside Captures Investor Interest

Candel Therapeutics, Inc. (NASDAQ: CADL), a burgeoning player in the biotechnology sector, is catching the attention of investors with its compelling potential upside of 305.50%. This clinical-stage biopharmaceutical company, headquartered..

Pacific Biosciences of California (PACB) Stock Analysis: Exploring a Potential 73% Upside

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading player in the healthcare sector, specializes in providing cutting-edge sequencing solutions designed to unravel genetically complex problems. With its robust portfolio..

Heron Therapeutics, Inc. (HRTX): Investor Outlook on a Potential 274% Upside

Heron Therapeutics, Inc. (NASDAQ: HRTX), a biotechnology firm operating within the healthcare sector, presents a tantalizing opportunity for investors, bolstered by an impressive potential upside of 274.02%. Headquartered in Cary,..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: A Promising 213.94% Upside in the Biotechnology Sector

Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company, stands out in the biotechnology industry with its innovative approach to treating life-threatening diseases through gene and cell therapies. The company,..

Outset Medical, Inc. (OM) Investor Outlook: A Compelling 90% Upside Potential

Outset Medical, Inc. (NASDAQ: OM), a trailblazer in the healthcare sector, is capturing investor attention with a promising potential upside of 90.18%, according to recent analyst ratings. As a company..

Chevron Corporation (CVX): Investor Outlook with a 6.97% Upside Potential

Chevron Corporation (NYSE: CVX), a stalwart in the energy sector, stands as one of the largest integrated oil & gas companies globally, with a commanding market capitalization of $317.92 billion...

Olema Pharmaceuticals, Inc. (OLMA): Analyst Ratings Signal 220% Upside Potential

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) has emerged as a noteworthy player in the biotechnology sector, focusing on the development of innovative therapies for women’s cancers. Based in San Francisco, this..

Senseonics Holdings, Inc. (SENS) Stock Analysis: A 226% Upside Potential in the Innovative Medical Device Sector

Senseonics Holdings, Inc. (NYSE: SENS) has captured investor attention with its pioneering approach in the healthcare industry, specifically within the medical device segment. Specializing in continuous glucose monitoring (CGM) systems,..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: A Mixed Bag of Prospects in the Veterinary Vaccine Market

Zhengye Biotechnology Holding L (ZYBT), a company rooted in the healthcare sector, operates primarily within the drug manufacturing industry, focusing on specialty and generic veterinary vaccines. Based in Jilin, China,..

UroGen Pharma Ltd. (URGN): Exploring a 76% Potential Upside in Biotechnology

UroGen Pharma Ltd. (NASDAQ: URGN) is capturing the attention of investors with its promising position in the biotechnology industry, particularly in the field of urothelial and specialty cancers. Based in..

Absci Corporation (ABSI) Stock Analysis: A Biotech Player with 241% Potential Upside

For investors eyeing the biotechnology sector, Absci Corporation (NASDAQ: ABSI) presents a fascinating opportunity. Specializing in AI-driven drug discovery, Absci operates at the intersection of cutting-edge technology and healthcare innovation...

Evolent Health, Inc (EVH) Stock Analysis: Exploring a 59.89% Potential Upside in Health Information Services

Evolent Health, Inc (NYSE: EVH) is making waves in the healthcare industry, specifically within the Health Information Services sector. With a market capitalization of $1.12 billion, this Arlington, Virginia-based company..

Integra LifeSciences Holdings C (IART): Analyzing the Healthcare Device Leader with a 1.24% Upside Potential

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a stalwart in the healthcare sector, specializes in medical devices that cater to a range of surgical and wound care applications. This Princeton, New..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Strong Buy Ratings Amid Biotech Growth

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is making waves in the biotechnology sector with its promising developments in the treatment of autoimmune diseases. Headquartered in Edmonton, Canada, the company is carving..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 46% Potential Upside in the Medical Innovation Sector

Pulse Biosciences, Inc. (NASDAQ: PLSE), a cutting-edge player in the healthcare sector, is capturing investor interest with a potential upside of 46.28%, as reflected in its current analyst ratings. Specializing..

The Pennant Group, Inc. (PNTG) Stock Analysis: Exploring a Potential 37% Upside in Healthcare

For investors seeking exposure in the healthcare sector, The Pennant Group, Inc. (NASDAQ: PNTG) presents an intriguing opportunity. With a market capitalization of $847.11 million, Pennant operates in the medical..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Assessing the 8.45% Upside Potential Amidst Volatile Metrics

Pacira BioSciences, Inc. (NASDAQ: PCRX) operates at the forefront of non-opioid pain management solutions within the healthcare sector. With its innovative product lineup and strategic industry positioning, this specialty drug..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 14.84% Potential Upside Amidst a Challenging Landscape

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specializing in diagnostics and research, offers a unique investment opportunity despite facing some headwinds. With a market capitalization of..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a Potential 25.98% Upside

For investors seeking opportunities within the healthcare sector, U.S. Physical Therapy, Inc. (NYSE: USPH) presents a compelling case. As a key player in the medical care facilities industry, USPH specializes..

Novavax, Inc. (NVAX) Stock Analysis: Investors Eye 61.71% Potential Upside Amid Volatile Market Conditions

Novavax, Inc. (NASDAQ: NVAX), a healthcare sector heavyweight specializing in biotechnology, is captivating investor attention with its substantial potential upside of 61.71%. This American company has carved a niche in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds